• BECOME A MEMBER
  • MEMBER LOG IN
  • FIND A CLINIC
  • ru
    • en
    • es
    • fr
    • da
    • it
    • cs
    • pl
    • nl
    • no
    • sv
    • pt
    • de
  • EHDN and
    Enroll-HD 2024
  • ABOUT HD
  • ABOUT EHDN
  • NEWS & EVENTS
  • HD Patients and Families
    • HD Patients and Families Home
    • Living with HD
    • Finding Clinics and Support
    • HD Research
  • HD Clinicians and Researchers
    • HD Clinicians and Researchers Home
    • Previous & Ongoing Research
    • Publications
    • EHDN Working Groups
    • Rater training and certification
    • Seed Fund Applications
    • Data-Mining Applications
    • Fellowship programme
    • Grant Management & Collaborations
  • Clinical Trial Sponsors
    • Clinical Trial Sponsors Home
    • Feasibility Assessment
    • Protocol Advice
    • Operational Support
    • Recruitment
    • Clinical Rater Training
    • HD Clinical Trial Site Certification Scheme
  • About Huntington's Disease
  • About EHDN
    • EHDN Structure
    • EHDN Working Groups
    • Grant Management & Collaborations
    • HD Clinics
    • Previous & Ongoing Research
    • Resources and Services
  • News & Events
  • REGISTRY LOGIN
  • MEMBER LOG IN
  • Find a Clinic
Skip to content
European Huntington's Disease Network
  • HD Patients and Families
    • Patients & Families Home
    • Living with HD
    • Finding Clinics and Support
    • HD Research
  • HD Clinicians and Researchers
    • Clinicians & Researchers Home
    • HD Science Think Tank
    • EHDN Working Groups
    • Fellowship programme
    • Seed Fund Applications
    • Grant management & Collaborations
    • Data-Mining Applications
    • Rater training and certification
    • Research & Publications
    • Guidelines
  • Clinical Trial Sponsors
    • Clinical Trial Sponsors Home
    • Protocol Advice
    • Feasibility Assessment
    • Operational Support
    • Recruitment
    • Clinical Rater Training
    • Site Certification Scheme

About: lisanne.muetze

Posts by lisanne.muetze:

  • UniQure Biopharma B.V. HD GeneTRX2 study endorsed* by EHDN, 30 мая 2023 in Uncategorized
  • Wave Life Sciences Ltd. SELECT-HD study endorsed* by EHDN, 30 мая 2023 in Uncategorized
  • Preliminary results of the Proof-HD trial, 27 Апр 2023 in Uncategorized
  • extract1_04/2023_NL-issue48, 11 Апр 2023 in Uncategorized
  • March 23rd: HUNTINGTON’s Gratitude Day 2023, 23 Мар 2023 in Uncategorized
  • EHDN Newsletter – 48th edition, 01 Мар 2023 in Uncategorized
  • HDYO International Young Adults Congress, 24 Фев 2023 in Uncategorized
  • CHDI’s 18th Annual Huntington’s Disease Therapeutics Conference, 20 Фев 2023 in Uncategorized
  • 28 February, 2023 IS RARE DISEASE DAY, 20 Фев 2023 in Uncategorized
  • PTC Therapeutics PIVOT-HD study endorsed* by EHDN, 16 Ноя 2022 in Uncategorized
  • Навигация по записям

    Предыдущие записи
    Следующие записи

Subscribe to
EHDN news

* Denotes required field
  • © EHDN 2016
  • Terms of Use
  • Privacy Policy
  • Contact EHDN
  • University of Ulm
LinkedIn